Acera Surgical, Inc. v. Nanofiber Solutions, LLC
This text of Acera Surgical, Inc. v. Nanofiber Solutions, LLC (Acera Surgical, Inc. v. Nanofiber Solutions, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
ACERCA SURGICAL, INC, ) RETECTIX, LLC and ) WASHINGTON UNIVERSITY, ) Plaintiffs, V. Civil Action No. 20-980-CFC/JLH NANOFIBER SOLUTIONS, LLC, PARAGEN TECHNOLOGIES LLC, ) ATREON ORTHOPEDICS LLC ) and RENOVODERM LLC, ) Defendants. ORDER Pending before me are Plaintiffs’ objections (D.I. 149) to the Magistrate Judge’s recommended construction of three terms in the Report and Recommendation she issued on October 12, 2022 (D.I. 147): (1) “first layer/second layer,” (2) “first layer/second layer/third layer,” and (3) “first plurality/second plurality.” I review de novo the Magistrate Judge’s conclusions with respect to claim construction. St. Clair Intell. Prop. Consultants, Inc. v. Matsushita Elec. Indus. Co., 691 F. Supp. 2d 538, 542 (D. Del. 2010). Plaintiffs argue that the Magistrate Judge’s recommended constructions “ignore the plain meaning of these easily understood terms and improperly limit
the claim scope.” D.I. 149 at 1. I agree that these terms are easily understood and should under normal circumstances be given their plain and ordinary meaning. But Plaintiffs’ distortion of the plain and ordinary meaning of “layer” and “plurality” made it necessary for the Magistrate Judge to engage in construction of the challenged terms in the first place. Under these circumstances, I see no error in the Magistrate Judge’s thoughtful Report and Recommendation and I adopt her construction of the disputed terms. NOW THEREFORE, on this 21st day of February in 2023, IT IS HEREBY ORDERED that: 1. Plaintiffs’ Objections to the Magistrate Judge’s Report and Recommendation (D.I. 149) are OVERRULED; and 2. The Report and Recommendation (D.I. 147) is ADOPTED.
(kh. □
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Acera Surgical, Inc. v. Nanofiber Solutions, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/acera-surgical-inc-v-nanofiber-solutions-llc-ded-2023.